| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Total income | 0.0 | 0.0 | 0.2 |
| Exceptional items | 0.0 | 0.0 | 0.6 |
| Net profit | -0.2 | -0.3 | 0.5 |
| Operating margin | 0.0% | 0.0% | 250.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: BIJHANS. Figures extracted from the filing.
Bijoy Hans Ltd: key numbers
- Share price
- ₹127.35
- Market cap
- ₹611.6 Cr
- Revenue (annual)
- ₹9.11 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 396.8×Sector 40.2×
- Promoter holding
- 30.62%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bijoy Hans Ltd
All →Arvaya Healthcare Annual General Meeting
Arvaya Healthcare Limited held its 41st Annual General Meeting on 21st September 2026, where members adopted financial statements and approved material related party transactions.
Arvaya Healthcare Merger & Restructuring Worth ₹0.8 Cr
Arvaya Healthcare has incorporated a wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, for an investment of ₹0.80 Crore. This entity will provide insurance broking services.
- Value
- ₹0.80 Cr
Arvaya Healthcare Other Announcement
Arvaya Healthcare Limited has dispatched web links to shareholders for accessing the Notice of its 41st Annual General Meeting and the Annual Report.
Arvaya Healthcare Annual Report
Arvaya Healthcare filed its 41st Annual Report for FY 2025-26, including the notice for the Annual General Meeting scheduled on 21 September 2026.
Arvaya Healthcare Annual General Meeting
Arvaya Healthcare Limited issued a Notice of its 41st Annual General Meeting to be held on 21 September 2026 via video conferencing. The agenda includes approval for material related party transactions.
Arvaya Healthcare Acquisition Worth ₹10 Cr
Arvaya Healthcare Limited approved the acquisition of a Copyright and Intellectual Property portfolio from Defib Institute of Health Solutions LLP for a consideration of ₹10 Crores.
- Value
- ₹10.00 Cr